DUATTI, Adriano
 Distribuzione geografica
Continente #
NA - Nord America 9.933
EU - Europa 3.197
AS - Asia 1.963
OC - Oceania 15
AF - Africa 12
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.137
Nazione #
US - Stati Uniti d'America 9.918
CN - Cina 1.107
UA - Ucraina 793
IT - Italia 597
DE - Germania 444
TR - Turchia 409
GB - Regno Unito 393
PL - Polonia 307
SE - Svezia 283
SG - Singapore 279
FI - Finlandia 209
VN - Vietnam 60
FR - Francia 47
IN - India 36
BE - Belgio 33
ID - Indonesia 23
IR - Iran 22
CZ - Repubblica Ceca 20
NL - Olanda 19
CA - Canada 15
AU - Australia 14
BG - Bulgaria 11
RU - Federazione Russa 11
AT - Austria 8
ZA - Sudafrica 8
EU - Europa 6
HU - Ungheria 5
MY - Malesia 5
RO - Romania 5
JP - Giappone 4
KR - Corea 4
TW - Taiwan 4
BO - Bolivia 3
CH - Svizzera 3
ES - Italia 3
PK - Pakistan 3
AR - Argentina 2
BR - Brasile 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
LB - Libano 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
IE - Irlanda 1
LI - Liechtenstein 1
MA - Marocco 1
ML - Mali 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
Totale 15.137
Città #
Woodbridge 1.186
Fairfield 1.178
Houston 901
Jacksonville 847
Chandler 781
Ann Arbor 722
Ashburn 627
Wilmington 502
Seattle 457
Cambridge 349
Warsaw 305
Nanjing 267
Izmir 256
Princeton 196
Addison 186
Beijing 168
Ferrara 165
Singapore 163
San Diego 114
Milan 108
Boardman 103
Shenyang 94
Nanchang 80
Los Angeles 69
Shanghai 69
Dearborn 60
San Mateo 60
Falls Church 59
Dong Ket 57
Hebei 57
Tianjin 57
New York 56
Changsha 52
Helsinki 48
Redwood City 43
Bremen 41
Jiaxing 38
Auburn Hills 28
Kunming 28
Brussels 27
Jinan 27
Ningbo 27
Norwalk 24
Zhengzhou 21
London 19
Amsterdam 18
Des Moines 18
Padova 18
Bologna 17
Legnaro 17
Jakarta 16
Washington 16
Mountain View 15
Taizhou 15
Guangzhou 14
Monmouth Junction 14
Philadelphia 14
Augusta 13
Brno 13
Hangzhou 12
Redmond 12
Verona 12
Leawood 11
Orange 11
Ardabil 9
Lanzhou 9
Munich 9
Mumbai 8
Vienna 8
Changchun 7
Haikou 7
Manduria 7
Woking 7
Ferrara di Monte Baldo 6
Olomouc 6
Rome 6
Stockholm 6
Toronto 6
Chengdu 5
Kuala Lumpur 5
L’Aquila 5
Parma 5
Penicuik 5
Tappahannock 5
Varese 5
Yellow Springs 5
Ariano nel Polesine 4
Bristol 4
Chicago 4
Edinburgh 4
Florence 4
Fuzhou 4
Guildford 4
Indiana 4
Islington 4
San Francisco 4
Santa Clara 4
Seoul 4
Surabaya 4
Taipei 4
Totale 11.195
Nome #
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 261
LARAMED: A Laboratory for Radioisotopes of Medical Interest 182
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 176
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 174
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of (Tc=N)2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of (S-methyl-3-(2-hydroxyphenyl-methylene) dithiocarbazato) nitrido (triphenylphosphine) Technetium(V) and bis(S-methyl-3- isopropylidene dithiocarbazato) nitrido Technetium(V). 147
A solvent-extraction module for cyclotron production of high-purity technetium-99m 144
THE STRUCTURE OF TRANS-DIBROMOOXO(N-PHENYLSALICYLIDENEAMINATO)(TRIPHENYLPHOSPHINE)RHENIUM (V), FORM-II (TRICLINIC), [REBR2(C13H10NO)O(P(C6H5)3)] 130
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 130
YAP-(S)PET small animal scanner: Quantitative results 129
Synthesis and characterization of technetium-(IV) and -(III) complexes with bidentate Schiff bases. X-ray molecular structure of chloro(dimethylphenylphosphine)bis(N-phenylsalicylideneiminato)technetium(III) 127
Photochemical synthesis and reaction of d6 metallocenes—tetracyanoethylene charge-transfer complexes 126
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 124
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 122
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 122
Synthesis, properties and X-ray crystal structure of Schiff base organo-imido complexes of rhenium(V) 121
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies 121
STRUCTURE OF TRANS-TRICHLOROBIS[DIETHYL(PHENYL)PHOSPHINE]HYDROXORHENIUM(IV) 120
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 120
The chemistry of heteroallyl derivatives of technetium. Reactivity of [TcNCl2(PPh3)2] and [Tc(CO)3Cl(PPh3)] with thiazetidine ligands. Crystal structures of [Tc(CO)2(PPh3)2PhN=C(OEt)S] and [TcN(Cl)(PPh3)PhN=C(OEt)S] 120
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 119
RHENIUM(V) COMPLEXES WITH VINYL AMIDES 118
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 118
Synthesis and Structure of an Amino Sugar-Schiff Base Complex of Technetium(V) Containing Salicylaldehyde in an Unusual Coordination Mode 117
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 117
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 117
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 1. Reactiv-ity of mixed carbonyl(formamido)(phosphine)rhenium(I) complexes with RNCS (R = Ph or p-MeC6H4) and PhNCO. Crystal structure of the thiazetidine rhenium(I) com-plex [Re(CO)2(PPh3)2PhN=C(OEt)-S] 116
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 116
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 116
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 115
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-]. 115
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 114
Synthesis and characterization of paramagnetic schiff base complexes of rhenium(IV) 113
null 113
Formation of the Tc≡N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals 113
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 113
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 113
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 113
PREPARATION AND CHARACTERIZATION OF MIXED AMIDO, CARBOXYLATO OR THIAZOLATO CARBONYL(PHOSPHINE)TECHNETIUM(I) COMPLEXES 112
Isolation and Crystal Structure of a Technetium(V) Nitrido Complex Containing a Coordinated Transient State of N-(2-Aminoethyl)carbamic Acid 111
Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium 111
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites 111
Chemistry and Bifunctional Chelating Agents for Binding Lu-177 111
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [Tc≡N]2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenylmethylene)dithiocarbazato]nitrido(triphenylphos-phine)technetium(V) and bis(S-methyl 3-isopropylidenedithiocarbazato)nitridotechnetium(V) 109
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 108
Synthesis and X-ray crystal structure of the mixed organoimido, organoamine rhe-nium(V) complex [ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 106
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 106
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 105
Reactivity of rhenium(I) pseudo-allyl complexes with heterocumulenes. Part 2. Inser-tion reactions. Crystal structures of the thiazolyl-thioureido and -dithiocarbamato complexes [Re(CO)2(PPh3)2SC(NPh)NMe(C3H2NS)] ·CH2Cl2 and [Re(CO)2(PPh3)2S2CNMe(C3H2NS)]·CH2Cl2 (C3H2NS = thiazol-2-yl) 104
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 104
Technetium(V) nitrido complexes with tetra-azamacrocycles: monocationic and neu-tral octahedral complexes containing the [Tc≡N]2+ core. Crystal structure of [TcN(L1)(H2O]·2H2O (H2L1 = 1,4,8,11-tetra-azacyclotetradecane-5,7-dione) 104
Molecular imaging with endogenous and exogenous ligands: the instance of antibodies, peptides, iodide and cupric ions 104
Synthesis and x-ray crystal structure of the mixed organoimido, organoamine rhenium(V) complex ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 103
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 103
Reactivity of Schiff base rhenium(V) complexes with dimethylphenylphosphine 102
null 102
Mixed schiff base, carbonyl(phosphine)rhenium(I) complexes 101
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 100
POLAROGRAPHIC AND SPECTROPHOTOMETRIC INVESTIGATION OF THE REDUCTION AND DEPROTONATION OF (1,3,6,8,10,13,16,19-OCTA-AZABICYCLO-[6,6,6]-ICOSANE)COBALT(III) ION, CO(SEP)3+, IN THE PRESENCE OF DIFFERENT ANIONS 100
BIS(DITHIOCARBAMATO) NITRIDO TC-99M RADIOPHARMACEUTICALS - A CLASS OF NEUTRAL MYOCARDIAL IMAGING AGENTS 99
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 2. Reactiv-ity of [ReO(OR)Cl2(PPh3)2] (R = Me or Et) with RNCS ( R = Ph or p-MeC6H4). Crystal structure of the thiazetidine rhenium(V) complex [ReOCl2(PPh3) p-MeC6H4N=C(OEt)-S] 99
Association of Co(sep)3+ ions with S2O32- ions: Spectrophotometric, circular dichroism and solubility measurements 99
REDOX PROPERTIES OF A SERIES OF PSEUDOALLYL RHENIUM(I) COMPLEXES 98
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 98
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 98
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 97
Reactivity of rhenium(I) pseudo-allyl complexes with heterocumulenes such as RNCS (R = Me or Ph, p-MeC6H4) and PhNCO. Part 1. Crystal structure determination of two isostructural monothio- and dithio-carbamate rhenium(I) complexes co-crystallized as [Re(CO)2(PPh3)2S=C(NHPh)-S]·[Re(CO)2(PPh3)2O-C(NHPh)=S 97
Nonisotopic substitution: Is fluorine a replacement for hydrogen? 97
In vivo imaging of oligonucleotides with nuclear tomography 96
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 96
Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine 95
Synthesis, reactivity and X-ray crystal structures of mixed thiazolato- or carboxylato-carbonyl(phosphine)-rhenium(I) complexes 95
Is PET always an advantage versus planar and SPECT imaging? 95
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 94
Is PET always an advantage versus planar and SPECT imaging? 93
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 92
BIODISTRIBUTION IN MAN OF BIS [(N-ETHYL, N-ETHOXY) DITHIOCARBAMATE] NITRIDO TECHNETIUM-(V), A PROMISING NEW TRACER FOR MYOCARDIAL PERFUSION IMAGING 89
Complexes of Tc(V) and Tc(III) with tridentate Schiff bases derived from S-Methyl dithiocarbazate. Crystal structures of chloro-[S-methyl-3-(2-hydroxy-1-naphtyl methylene) dithiocarbazato(2-)]oxotechnetium(V) and dichloro[S-methyl-3-(2-hydroxybenzilidene) dithiocarbazato(1)]bis (triphenylphosphine) technetium(III). 88
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 88
Technetium complexes and radiopharmaceuticals with scorpionate ligands 87
Crystal structure of trans-dicarbonylbis (dimethylphenylphoshine)(N-phenylsalicyl ideneaminato) rhenium(I) and mer-trichloro (dimethylphenylphosphine)(N-phenylsalicyl ideneaminato) rhenium(IV). Comparison of Re(I), Re(III), Re(IV) and Re(V) complexes with salicylideneaminato ligand and reaction mechanism. 85
UPTAKE MECHANISM OF THE NEUTRAL MYOCARDIAL IMAGING AGENT TC-99MN-NOET 84
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 84
Extraction techniques of 99mTc from 100Mo Metal Target 84
null 82
Radiofarmaci 81
null 80
COMPLEXES OF TC-V AND TC-III WITH TRIDENTATE SCHIFF-BASES DERIVED FROM S-METHYL DITHIOCARBAZATE - CRYSTAL-STRUCTURES OF CHLORO[S-METHYL 3-(2'-HYDROXY-1-Synthesis and Characterization of paramagnetic triazenido-complexes of rhenium(III). The crystal structure of [ReCl2(p-MeC6H4N−N−NC6H4Me-p)(PPh3)2] 79
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 79
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 79
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 79
INTERACTION OF THE MYOCARDIAL IMAGING AGENT TCN-NOET WITH CYCLODEXTRINS - INFLUENCE OF THE STABILITY OF THE INCLUSION COMPLEX ON THE BIOLOGICAL PROPERTIES 78
Subcellular distribution of technetium-99m-N-NOEt in rat myocardium 78
A small animal hybrid PET-SPECT scanner: First in-vivo results. 78
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 78
A NEW EFFICIENT METHOD FOR THE PREPARATION OF TC-99M-RADIOPHARMACEUTICALS CONTAINING THE TCN MULTIPLE BOND 77
Formation of the Trans-[Re(O2)]+ Group from the Reactions of ReNCl2(PPh3)2, ReCl4(PPh3)2, and ReCl3(CH3CN)(PPh3)2 with Chelating Amines and Tetraazamacrocycles. Crystal Structure Of Trans-[ReO2(Cyclam)](PF6) (Cyclam = 1, 4, 8, 11-Tetraazacyclotetradecane) 77
Reactivity of 2-(2-hydroxyphenyl)benzothiazoline with the oxotetrahalometalate(V) complexes [MOX4]- (M = technetium, rhenium; X = Cl, Br). Synthesis and characterization of new oxo-M(V) complexes containing 2-(2-hydroxyphenyl)benzothiazole. Crystal structure of tetraphenylarsonium oxotrichloro[2-(2-hydroxyphenyl)benzothiazolato]technetate(V) 77
Reactions of the Technetium(I) Carbonyl Complexes [Tc(PMe2Ph)3(CO)2Cl] and [Tc(PPh3)2(CO)3Cl] toward Pseudoallyl Ligands Such as Triazenido, Formamidinato, and Acetamidinato. Crystal Structures of [Tc(PMe2Ph)2(CO)2(p-CH3C6H4N-N-NC6H4CH3-p)] and [Tc(PMe2Ph)2(CO)2(C6H5N-C(CH3)-NC6H5)] 76
STUDIES OF THE SUBCELLULAR-DISTRIBUTION OF BIS[(N-ETHYL, N-ETHOXY)DITHIOCARBAMATO] NITRIDO TECHNETIUM(V) (TCN-NOET) BY CELL FRACTIONATION TECHNIQUES 75
Crystal structures of trans-dicarbonylbis(dimethylphenylphosphine)(N-phenylsalicyl-ideneaminato)rhenium(I) and mer-trichloro(dimethylphenylphosphine)(N-phenyl-salicylideneaminato)rhenium(IV). Comparison of ReI, ReIII, ReIV, and ReV complexes with salicylideneaminato ligand and reaction mechanisms 74
Totale 10.643
Categoria #
all - tutte 68.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.138
Totale 73.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.483 0 107 83 405 169 333 287 307 229 386 120 57
2020/20212.392 190 183 102 266 60 234 75 328 86 340 364 164
2021/20222.184 79 200 172 95 141 75 91 122 81 159 289 680
2022/20231.801 214 125 45 226 261 281 104 152 194 22 125 52
2023/2024984 93 116 81 39 64 108 72 64 19 28 29 271
2024/2025235 139 96 0 0 0 0 0 0 0 0 0 0
Totale 15.423